Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02279199 · ClinicalTrials.gov registry record
Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)
A clinical trial of Hemophilia, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 45
- Enrollment target
- 2
- Study locations
NCT02279199 is a study of Hemophilia that has completed, run by Oregon Health and Science University. The registered enrollment target is 45 participants, below the 405-participant average among 9 other Hemophilia trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02279199, a study of Hemophilia, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to find out if gross motor skills of children and young adults with bleeding disorders are different from those without bleeding disorders. The investigators will use the standardized motor test the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2 tm). The second purpose is to establish if history of joint disease secondary to bleeding affects gross motor skills. 1. Participants and setting: Subjects will include up to 100 male youth and young adults, ages 4 to 21, recruited from the patient population of the Hemophilia Treatment Center at OHSU. A mailing that describes the study may be sent to all potential subjects who receive care through the Hemophilia Treatment Center at OHSU. Data collection will occur at either clinic visits or in the home. Information, including history of change in joint structure and synovium, from existing bleeding disorder repositories at OHSU will also be used. 2. Design and Procedures: Research will be done using a prospective, cross-sectional study design to examine any relationship between a diagnosis of bleeding disorder and gross motor development. The gross motor ability of children and young adults with bleeding disorders who meet the inclusion criteria will be compared to sex-specific normative data from a standardized motor test. Information about age, type of hemophilia, presence of an inhibitor, type of management used, body composition, range of motion, and hand strength will also be collected through direct measurement and chart review. The information collected will be entered into a repository. A subject may choose to opt out of the repository while still participating in the research study. In addition, information from a current hemophilia repository will be compared to gross motor ability scores to determine if joint disease is related to skill level in this group of people. 3. Proposed analyses: Two-tailed t tests and logistic regression will be used to determine if th
Conditions Studied
Study Locations (2)
Oregon
- Oregon Health and Science University - Portland
- Patient's home - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-01 |
| Est. Completion | 2022-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02279199
The ClinicalTrials.gov registry entry for NCT02279199 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 405-participant average among 9 other Hemophilia trials with a reported enrollment target (89% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemophilia appearing as the primary indexed condition, and to 0 interventions.
NCT02279199 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT02279199 about?
NCT02279199 is a clinical study titled "Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)". The purpose of this study is to find out if gross motor skills of children and young adults with bleeding disorders are different from those without bleeding disorders. The investigators will use the standardized motor test the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2 tm)...
What is the current status of trial NCT02279199?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2014-01. Estimated completion is 2022-01.
What conditions does trial NCT02279199 study?
This clinical trial studies the following conditions: Hemophilia.
Who is sponsoring clinical trial NCT02279199?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02279199 being conducted?
This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
RECRUITING · Early Phase 1
-
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RECRUITING · Phase 3
-
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
ACTIVE NOT RECRUITING · Phase 3
-
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.